TBI [total body irradiation] with fludarabine conditioning followed by transplantation with combined umbilical cord blood grafts.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fludarabine (Primary)
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Therapeutic Use
- 16 May 2014 Biomarkers information updated
- 17 Feb 2012 Planned end date changed from 1 Sep 2011 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 07 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.